COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 164 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $972,374 | +22.5% | 43,507 | +17.7% | 0.63% | +31.1% |
Q2 2023 | $794,055 | +11.7% | 36,950 | +24.7% | 0.48% | +5.7% |
Q1 2023 | $710,695 | -35.7% | 29,625 | -37.8% | 0.45% | -41.2% |
Q4 2022 | $1,104,975 | +51.8% | 47,628 | +4.8% | 0.77% | +47.4% |
Q3 2022 | $728,000 | -14.6% | 45,435 | -5.5% | 0.52% | -13.6% |
Q2 2022 | $852,000 | -8.3% | 48,087 | +5.4% | 0.60% | +3.2% |
Q1 2022 | $929,000 | +17.6% | 45,613 | +7.8% | 0.59% | +25.2% |
Q4 2021 | $790,000 | -4.2% | 42,312 | +1.3% | 0.47% | -12.4% |
Q3 2021 | $825,000 | -6.2% | 41,773 | +12.2% | 0.53% | -10.6% |
Q2 2021 | $880,000 | +12.8% | 37,222 | +13.1% | 0.60% | +3.6% |
Q1 2021 | $780,000 | -0.3% | 32,897 | -15.7% | 0.58% | -7.5% |
Q4 2020 | $782,000 | +20.3% | 39,039 | +25.0% | 0.62% | +4.4% |
Q3 2020 | $650,000 | +52.9% | 31,241 | +28.5% | 0.60% | +41.8% |
Q2 2020 | $425,000 | +6.9% | 24,309 | -0.1% | 0.42% | -11.7% |
Q1 2020 | $397,549 | -51.2% | 24,345 | -38.5% | 0.48% | -39.4% |
Q4 2019 | $815,000 | – | 39,599 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |